ADRA2C anticorps (C-Term)
Aperçu rapide pour ADRA2C anticorps (C-Term) (ABIN5883501)
Antigène
Voir toutes ADRA2C AnticorpsReactivité
Hôte
Clonalité
Conjugué
Application
-
-
Épitope
- AA 442-462, C-Term
-
Séquence
- QDFRRSFKHI LFRRRRRGFR Q
-
Purification
- Protein G Purified
-
Immunogène
- Synthetic peptide amino acids 442- 462 (QDFRRSFKHILFRRRRRGFRQ, cytoplasmic C-terminus) of human Alpha-2C adrenergic receptor
-
Isotype
- IgG1
-
-
-
-
Indications d'application
- Optimal working dilution should be determined by the investigator.
-
Restrictions
- For Research Use only
-
-
-
Format
- Liquid
-
Concentration
- 1 mg/mL
-
Buffer
- PBS pH 7.4, 50 % glycerol, 0.09 % sodium azide
-
Agent conservateur
- Sodium azide
-
Précaution d'utilisation
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Stock
- -20 °C
-
Stockage commentaire
- Store at -20 °C.
-
-
- ADRA2C (Adrenergic, alpha-2C-, Receptor (ADRA2C))
-
Autre désignation
- Alpha-2C Adrenergic Receptor
-
ID gène
- 152
-
UniProt
- P18825
-
Pathways
- EGFR Signaling Pathway, cAMP Metabolic Process
Antigène
-